
About Ruslan Novo Pharmaceutical Private Limited
Data last updated:
Ruslan Novo Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 November 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017PTC301377. Its GSTIN is 23AAICR6000L1ZI (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Harshika Dubey and Amit Kumar Joshi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.74 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹39,346 (net margin 1%) and EBITDA of ₹61,574 (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹7.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ruslannovo.com.
Company details
Recognitions & Rankings of Ruslan Novo Pharmaceutical
Contact details
Ruslan Novo Pharmaceutical Private Limited's registered office is in Mumbai, Maharashtra. Its website is ruslannovo.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No. 119 1st Floor Mastermind – V Royal Palms Aarey Milk Co, Lony, Mumbai, Maharashtra, India – 400065
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ruslan Novo Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ruslan Novo Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Ruslan Novo Pharmaceutical Private Limited, buy the company report.
Financials of Ruslan Novo Pharmaceutical Private Limited
FY 2024 filings availableRuslan Novo Pharmaceutical Private Limited reported revenue of ₹38.74 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 3% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹61,574 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39,346 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ruslan Novo Pharmaceutical Private Limited, buy the company report.
Board of directors of Ruslan Novo Pharmaceutical Private Limited
Ruslan Novo Pharmaceutical has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harshika Dubey | Director | 25 Jul 2023 | 3 Years 3 Months | Current |
| Amit Kumar Joshi | Director | 16 Apr 2024 | 2 Years 7 Months | Current |
| Kavita Joshi | Director | 01 Nov 2017 | 9 Years 0 Months | Current |
Peer comparison
Ruslan Novo Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Emtris Consulting Private Limited | ₹38.9 Lakh (FY 2025) | 1.0% | Pune, Maharashtra, India | |||
| Cutishine Pharmaceuticals Private Limited | ₹38.85 Lakh (FY 2025) | 115.0% | Indore, Madhya Pradesh, India | |||
| Ranisati Financial Management Private Limited | ₹38.81 Lakh (FY 2025) | -1.0% | Howrah, West Bengal, India | |||
| SCM Groups Private Limited | ₹38.78 Lakh (FY 2025) | -61.0% | Tiruppur, Tamil Nadu, India | |||
| Vishwa Tradecom Pvt Ltd | ₹38.75 Lakh (FY 2025) | 67913.0% | Kolkata, West Bengal, India | |||
| Ruslan Novo Pharmaceutical Private Limitedthis company | ₹38.74 Lakh (FY 2025) | ₹39,346 | 1% | 3.0% | Mumbai, Maharashtra, India | |
| Akurab Health Care Private Limited | ₹38.73 Lakh (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Maxella Dreams Private Limited | ₹38.71 Lakh (FY 2025) | 35.0% | New Delhi, Delhi, India | |||
| P T Infrastructures Private Limited | ₹38.7 Lakh (FY 2025) | 8.0% | Delhi, India | |||
| Avichi Global Impex Private Limited | ₹38.62 Lakh (FY 2025) | Bhopal, Madhya Pradesh, India | ||||
| Byennet Pharmaceutical Private Limited | ₹38.62 Lakh (FY 2025) | 0.0% | Aurangabad, Maharashtra, India |
To see the full peer comparison of Ruslan Novo Pharmaceutical Private Limited, buy the company report.
Auditor
Ruslan Novo Pharmaceutical Private Limited is audited by Nam & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Nam & Associates | FY 2023 | 014430C |
Shareholding
The shareholding of Ruslan Novo Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ruslan Novo Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jun 2022 | 100588883 | Bank of India | ₹7.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ruslan Novo Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ruslan Novo Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ruslan Novo Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAICR6000L1ZI | Madhya Pradesh | Active | 16 Nov 2017 |
To see the full GST registrations and return filing status of Ruslan Novo Pharmaceutical Private Limited, buy the company report.
Recent activity
Ruslan Novo Pharmaceutical Private Limited has 5 board changes on record since 2017: 3 appointments and 2 cessations. The latest: Amit Kumar Joshi was appointed as Director on 16 Apr 2024.
Frequently asked questions
Ruslan Novo Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 November 2017 (9+ years old) and is registered under CIN U51909MH2017PTC301377.
Ruslan Novo Pharmaceutical has 3 current directors:
- Harshika Dubey - Director
- Amit Kumar Joshi - Director
- Kavita Joshi - Director
The latest financial statements of Ruslan Novo Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Ruslan Novo Pharmaceutical is 23AAICR6000L1ZI, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Ruslan Novo Pharmaceutical is U51909MH2017PTC301377. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ruslan Novo Pharmaceutical was incorporated on 01 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Ruslan Novo Pharmaceutical by revenue are Emtris Consulting Private Limited, Cutishine Pharmaceuticals Private Limited, Ranisati Financial Management Private Limited, SCM Groups Private Limited, Vishwa Tradecom Pvt Ltd and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Amit Kumar Joshi was appointed as Director on 16 Apr 2024. Harshika Dubey ceased to be Additional Director on 29 Sep 2023. Amit Kumar Joshi ceased to be Director on 07 Aug 2023. Ruslan Novo Pharmaceutical has 5 board changes on record in total.
Yes, Ruslan Novo Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Ruslan Novo Pharmaceutical can be reached through the website ruslannovo.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Ruslan Novo Pharmaceutical is at Office No. 119 1st Floor Mastermind – V Royal Palms Aarey Milk Co, Lony, Mumbai, Maharashtra, India – 400065.

